Here, we focused on clinical and pathological characterization of PD-L1 expression on whole sections of meningioma cases and correlated PD-L1 expression with patient outcome to gain a better understanding of its prognostic clinical utility and identify its potential regulatory mechanisms in meningiomas. The gene discussed is CD274; the disease is meningioma.